Feature Anticoagulants Concerns over data in key dabigatran trial BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4747 (Published 23 July 2014) Cite this as: BMJ 2014;349:g4747 Article Related content Metrics Responses Peer review Related articles Feature Dabigatran: how the drug company withheld important analyses Published: 23 July 2014; BMJ 349 doi:10.1136/bmj.g4670 Editorial The trouble with dabigatran Published: 23 July 2014; BMJ 349 doi:10.1136/bmj.g4681 Analysis Dabigatran, bleeding, and the regulators Published: 23 July 2014; BMJ 349 doi:10.1136/bmj.g4517 Editorial Safety of new oral anticoagulants Published: 24 April 2015; BMJ 350 doi:10.1136/bmj.h1679 Research Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study Published: 24 May 2016; BMJ 353 doi:10.1136/bmj.i2607 Editorial Novel oral anticoagulants for atrial fibrillation Published: 28 September 2016; BMJ 354 doi:10.1136/bmj.i5187 See more Stroke: Take test for genetic variant to ensure clopidogrel works for prevention, says NICE BMJ May 19, 2023, 381 p1146; DOI: https://doi.org/10.1136/bmj.p1146 David Oliver: What the plan for social care omitted BMJ September 10, 2021, 374 n2227; DOI: https://doi.org/10.1136/bmj.n2227 Stroke: “striking reductions” are seen in number of people with symptoms seeking help BMJ April 06, 2020, 369 m1406; DOI: https://doi.org/10.1136/bmj.m1406 NICE recommends implantable monitor to identify atrial fibrillation after stroke BMJ January 14, 2020, 368 m133; DOI: https://doi.org/10.1136/bmj.m133 Thrombectomy can be considered up to 24 hours after onset of stroke, says NICE BMJ November 23, 2018, 363 k4995; DOI: https://doi.org/10.1136/bmj.k4995 Cited by... Novel oral anticoagulants for atrial fibrillationFulltext PDF Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort studyFulltext PDF Abstract Dabigatran: how the drug company withheld important analysesFulltext PDF Abstract
